Management of diabetes mellitus and assignment of insulin treatment depend on the observed symptoms and patient characteristics (body mass index, polyuria, polydipsia, the dynamic of weight gain/loss), and may require evaluation of β-cells status, presence of auto-antibodies and ketone bodies, and levels of C-peptide [49]. This evidence concerns the gene INS and diabetes mellitus.